Latest Gene Therapy news
FDA Approves Breyanzi for Relapsed, Refractory Marginal Zone Lymphoma
posted December 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASH: Sustained Benefit Seen for Etranacogene Dezaparvovec in Hemophilia B
posted December 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Lentiviral Gene Therapy Shows Sustained Clinical Efficacy for ADA-SCID
posted October 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
Exa-Cel Gene Therapy Improves Quality of Life in Severe Sickle Cell Disease
posted September 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds 
Gene Mutation Identified That Increases Lung Cancer Risk 
Oral Vitamin C Active in Clonal Cytopenia of Undetermined Significance 
Family History of CRC Increases CRC Risk Similarly in IBD, General Population Related Articles
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer 
Revakinagene Taroretcel Reduces Ellipsoid Zone Area in Macular Telangiectasia Type 2 
Gene Therapy Effective in Patients With Recessive Dystrophic Epidermolysis Bullosa Monthly Specialist Briefings
Stay Connected
